Journal
JOURNAL OF IMMUNOLOGY
Volume 180, Issue 4, Pages 2039-2043Publisher
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.180.4.2039
Keywords
-
Categories
Funding
- NCI NIH HHS [1R01 CA 91839] Funding Source: Medline
- NIAID NIH HHS [1R01 AI 059638] Funding Source: Medline
Ask authors/readers for more resources
Mast cell activation is associated with atopic and inflammatory diseases, but the natural controls of mast cell homeostasis are poorly understood. We hypothesized that CD4(+) CD25(+) regulatory T cells (Treg) could function in mast cell homeostasis. In this study, we demonstrate that mast cells can recruit both Treg and conventional CD4+ T cells (Tconv). Furthermore, Treg, but not Tconv, suppress mast cell Fc epsilon RI expression. Despite the known inhibitory functions of IL-10 and TGF beta 1, FcFRI suppression was independent of IL-10 and TGF-beta 1 and required cell contact. Surprisingly, coculture with either Treg or Tconv cells suppressed IgE-mediated leukotriene C4 production but enhanced cytokine production by mast cells. This was accompanied by a selective increase in Fc epsilon RI-mediated Stat5 phosphorylation, which is a critical mediator of IgE-mediated cytokine secretion. These data are the first direct demonstration that mast cells can recruit Treg and illustrate that T cell interactions can alter the mast cell response.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available